BLOG
MVD Studies From Around the Country
Virginia Tech and Auburn University are enrolling dogs in studies to further research in the area of Mitral Valve Disease. If you are opting not to have surgery to correct the mitral valve defect, these could be options for your dog and would help further research in this very important area for our community!
Spironolactone Study at Virginia Tech
This study is looking at whether adding spironolactone (a diuretic commonly used in human medicine) to conventional therapy for congestive heart failure will improve pulmonary hypertension caused by mitral valve disease. There’s also a bit more information on our website: http://www.vetmed.vt.edu/clinical-trials/current-studies/spironolactone.asp.
Dogs must be seen at the Veterinary Teaching Hospital here in Blacksburg, VA. There are required follow-up visits at Day 7 and Day 30 after enrollment, so it’s probably not a practical study for anyone outside of easy driving distance.
Entresto Study at Auburn University
"Entresto, a highly effective drug used in treating human heart patients, is being evaluated at Auburn University’s College of Veterinary Medicine for use with dogs.
A clinical trial for the drug is underway in the Cardiology Service at the Wilford and Kate Bailey Small Animal Teaching Hospital. Pet owners can begin registering to participate in the two-year study that costs nothing but a $75 screening and examination fee, says Dr. Daniel Newhard, a cardiology resident at the college and chief physician conducting the trial. Although the entire trial is a two-year program, each dog participates for only 30 days, he notes."
Continue reading about the study here.
To inquire or to register for participation in this clinical trial, call (334) 844-4690, or contact Dr. Newhard by email at dkn0004@auburn.edu.